The Chemours Company Reports Fourth Quarter and Full Year 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Chemours (CC) Tops Q4 EPS by 6c, FY EPS Guidance Misses
February 14, 2019 4:17 PM ESTChemours (NYSE: CC) reported Q4 EPS of $1.05, $0.06 better than the analyst estimate of $0.99. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.51 billion.
The company expects to deliver 2019 Adjusted EBITDA within a range of $1.35 to $1.6 billion. Capital expenditures are... More
